Paul Goldsmith

Co-founder, Director, Closed Loop Medicine Ltd; Non Executive Director at MHRA, visiting Professor, IGHI, Imperial College; trustee Big Tent foundation; NHS Clinical Senate and practising p/t consultant physician

Summary

Dr. Paul Goldsmith, MA BM BCh MRCP PhD, is a well-rounded professional with a strong background in founding and developing life sciences companies in the drug and digital therapeutics sectors.
He brings with him extensive experience in frontline clinical medicine and complex systems strategy, along with a special interest in evolutionary biology and its application to modern challenges.
His impressive credentials include a Doctor of Philosophy (PhD) in Developmental Biology and Neuroscience from the University of Cambridge, as well as a MA in Triple 1st and a BM BCh in Clinical Medicine from the University of Oxford.
Dr. Goldsmith has played key roles in various organizations, including serving as a Non-Executive Director at the Medicines and Healthcare products Regulatory Agency and holding positions in renowned institutions like the Royal College of Physicians.
He has been actively involved in the healthcare sector, working in roles such as Non-Executive Director at MDU Investments Limited and MDU Ltd, and contributing as a former Part-time Consultant Neurologist at the NHS.
His professional journey has seen him co-founding and directing companies like Closed Loop Medicine Ltd, Vastrata Ltd, DanioLabs, and being part of the relaunch team at Ieso Digital Health.
Dr. Goldsmith's research contributions are also noteworthy, having worked as a Research Fellow at UCSF and authored policy papers across various domains.
His commitment to driving innovation is further evident in his roles as President of Closed Loop Medicine and a Senior Fellow at esteemed institutions like the Centre for Policy Studies and Radix.